Press Release|Articles|December 2, 2024

Camber Pharmaceuticals Introduces Lidocaine HCI Injection, USP, in Single- and Multi-Dose Vials

Listen

0:00 / 0:00

Key Takeaways

Camber Pharmaceuticals introduces Lidocaine HCl Injection in single-dose and multi-dose vials with 1% and 2% concentrations.
The product is available in various vial and pack sizes to meet diverse healthcare needs.
Camber, a subsidiary of Hetero, focuses on delivering high-quality generic medications for cost-effective healthcare solutions.
Expertise in APIs and finished dosage manufacturing ensures global access to affordable, reliable pharmaceuticals.

Featuring 1% and 2% concentrations, this versatile product is available in various vial and pack sizes to meet diverse healthcare needs.

Camber Pharmaceuticals is excited to introduce Lidocaine HCl Injection, USP, in Single-Dose and Multi-Dose Vials. Featuring 1% and 2% concentrations, this versatile product is available in various vial and pack sizes to meet diverse healthcare needs.

Click below to learn more:

Single-Dose Vials: https://www.camberpharma.com/products/lidocaine-sdv/
Multi-Dose Vials: https://www.camberpharma.com/products/lidocaine-mdv/

Camber Pharmaceuticals, a fully integrated pharmaceutical company, is dedicated to delivering high-quality generic medications that enhance lives through cost-effective healthcare solutions. As a subsidiary of Hetero, a global leader in active pharmaceutical ingredients (APIs) and finished dosage manufacturing based in Hyderabad, India, Camber leverages its expertise to ensure access to affordable, reliable pharmaceuticals for consumers worldwide.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

On-Demand Virtual Symposium

Harnessing the Potential of SGLT2 Inhibitors in Cardiorenal Metabolic Health: Strategies for Long-term Care and Consultant Pharmacists

1.0 Credit / Cardiology, Endocrinology, Diabetes, & Metabolism, Nephrology

Camber Pharmaceuticals Introduces Lidocaine HCI Injection, USP, in Single- and Multi-Dose Vials

Key Takeaways

Newsletter

Related Content

Camber Launches Abacavir and Lamivudine Tablets, USP

Camber Launches Colchicine Capsules

Camber Pharmaceuticals Adds Metformin Hydrochloride Oral Solution to Growing Portfolio

Camber Launches Prucalopride Tablets

Camber Announces Addition of Chlorpromazine HCl Injection, USP

Latest CME

Harnessing the Potential of SGLT2 Inhibitors in Cardiorenal Metabolic Health: Strategies for Long-term Care and Consultant Pharmacists

How Artificial Intelligence Is Transforming Cancer Care: Essential Insights for Oncology Pharmacists

Charting the Course: The Pharmacist's Role in Safeguarding Patients From Immune-Related Adverse Events

The Evolving Treatment Landscape of Migraine

The Role of the Pharmacist Migraine Management

Guiding Bispecific Antibody Use in Non-Hodgkin Lymphoma: Integrating Evidence and Enhancing Care

Strategies to Reduce Challenges in the Management of Chronic Rhinosinusitis with Nasal Polyps: The Role of Biologic Therapy

Navigating the New Wave in Targeted Therapies for Acute Myeloid Leukemia: A Focus on IDH and FLT3 Mutations

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

Exploring HIV Long-Acting Injectable Uptake: How Pharmacists Can Encourage Long-Acting Injectables to Stem the Spread of HIV

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

Improving the Care of Persons Living With Diabetes Using CGM Devices (Pharmacy Technician Credit)

Continuous Glucose Monitoring: What's New in 2025?

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake

Beyond the Prescription: Tackling Social Isolation for Better Health (Pharmacy Technician Credit)

Evaluating the Role of Pharmacists in Utilizing Potassium-Competitive Acid Blockers for Acid Peptic Disorders

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases

Balancing Pain Management and Opioid Use Disorder: Recognition, Treatment, and Compassionate Communication in Pharmacy Practice

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Advancing Multiple Sclerosis Treatment: Exploring Evolving Therapies and Patient-Centered Approaches

New and Emerging Therapies for the Management of Narcolepsy: A Guide to Patient-Centered Care

Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

Exploring ATTR Phenotypes and Identifying Appropriate Opportunities for Pharmacists to Intervene

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Advances in Castration-Sensitive Prostate Cancer: A Pharmacist's Approach to Optimize Novel Antiandrogen Therapies

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

Understanding the Pearls and Pitfalls of Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Opportunities to Improve Patient Outcomes

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

Optimizing Therapy in HR+/HER2-Negative Metastatic Breast Cancer: Navigating Novel Treatments and Personalized Care

Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Risk Populations and Vaccine Uptake

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Glucagon for Diabetes: Overcoming Barriers for Optimal Management in the Long-Term Care Setting

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Directions in Oncology Pharmacy® 2025: Northeast

Transforming Small Cell Lung Cancer Management With DLL3-Targeted Therapies

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

Cytokine Release Syndrome With Bispecific Antibodies: A Pharmacist's Guide to Safe Management

Advancing Chronic Kidney Disease Detection and Cardiovascular Risk Reduction in Complex Patients

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Enhancing Endometrial Cancer Management: Highlights of Molecular Insights, Treatment Approaches, and Toxicity Management

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Enhancing Safety in Cancer Care: Expert Guidance on Toxicity Management of HER2, TROP2, and HER3-Targeted Antibody-Drug Conjugates

Exploring the Role of Glucagon Like Peptide Receptor 1 Agonists (GLP-1RA) in the Treatment of Obesity (Pharmacist Credit)

A Pharmacist's Guide to the Safe and Effective Management of BTK and BCL-2 inhibitors in Chronic Lymphocytic Leukemia

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians (Pharmacy Technician Credit)

The Educated Pharmacist: Overcoming Clinical Inertia - An Interactive Case Workshop for Optimizing Insulin Use

Two Targets, One Mission: Optimizing Bispecific Antibody Use in Non-Hodgkin Lymphoma

Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Lymphomas: A Practical Guide for Pharmacists

Advancements in Extensive-Stage Small Cell Lung Cancer Therapy: Integrating Clinical Evidence to Fill Gaps in Care

Overview and Burden of Migraine

Mastering Hypertrophic Cardiomyopathy: Cutting-Edge Therapies for Better Outcomes

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

Emerging Biologic Therapy for the Management of COPD: Integrated Approaches to Optimized Care

The Impact and Role of Pharmacists in the Management of Specialty Therapies

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

Optimizing Treatment Strategies: A Comprehensive Approach to Primary Biliary Cholangitis and Pruritus

Exploring Advances in the Management of DOAC-Associated Bleeding With Reversal Agents: Role of the Health-System Pharmacists

Combating Opioid Overdoses: The Impact of Pharmacist-led Counseling and Dispensing of Opioid Reversal Agents

Multidisciplinary Perspectives and Patient-Centered Approaches in Newly Diagnosed Multiple Myeloma

New and Approved: FDA’s 2024 Drug Lineup (Pharmacy Technician Credit)